Medicine
The Psychedelics Evangelist: A German Financier Wants to Turn Magic Mushrooms into Modern Medicine
One company the entrepreneur invests in wants to develop psilocybin in a lab—so no need to extract it from mushrooms
STAT
Medicine
Fed Up with Washington, ALS Advocates Consider ACT UP’s Take-No-Prisoners Approach
Patients want drugs fast-tracked through FDA approval process
Policy
Congress Revives Ban on Altering the DNA of Human Embryos Used for Pregnancies
Some scientists had called for lifting the ban to allow the U.S. Food and Drug Administration to evaluate the new technologies
Medicine
Is $2.1 Million Too Much for a Drug? For Affected Parents, There Is No Debate
Similarly effective drugs in the pipeline will also be gauged against their enormous price tags
Policy
At First-Ever Public Hearing on CBD, FDA and Advocates Try to Blaze Trail to Regulatory Compromise
Agency officials press sometimes confused stakeholders for more data. Is it possible to define a “more effective CBD cosmetic?”
Public Health
U.S. Measles Cases Top 700 This Year as Health Officials Urge Vaccinations
The surge in cases has sent 66 children to the hospital, according to the Centers for Disease Control and Prevention
Policy
Stanford Clears Three Faculty Members of “CRISPR Babies” Involvement
A review concluded that the scientists did not take part in a Chinese researcher’s experiment to edit the genomes of twin human embryos
Biotech
The Case of a Woman Who Feels Almost No Pain Leads Scientists to a New Gene Mutation
The discovery may have implications for treating acute and chronic pain
Medicine
Biogen Halts Studies of Closely Watched Alzheimer’s Drug, a Blow to Hopes for New Treatment
Trial failure raises doubts about amyloid as a target for drug development
Medicine
FDA Approves First New Drug Developed for Women with Postpartum Depression
The new drug, Zulresso, can work in days, not the weeks it takes for current treatments
